Our purpose was to see how other biomarkers, CEA, CA125, and AFP, and blood parameters of parathyroid and thyroid glandular dysfunction interplay with CA15-3, the most commonly used tumor marker in breast cancer. The gene discussed is MUC16; the disease is breast cancer.